Back to search

Aristotle University Of Thessaloniki (AUTH)

Σκληροστίνη και πρωτεΐνη Dickkopf-1 και αρτηριακή σκληρία σε ασθενείς με χρόνια νεφρική νόσο σταδίου 5 σε χρόνια περιοδική αιμοκάθαρση

Abstract

dc:description

AIM: Abnormalities of mineral and bone metabolism, including vascular calcifications, appear to play a significant role in arteriosclerotic vascular changes in CKD patients. Renal function decline leads to imbalance of several promoters and inhibitors of extraosseous bone formation, including the novel bone proteins sclerostin and Dkk-1, which are inhibitors of the canonical Wnt/β-catenin signalling pathway of the osteoblasts. The main purpose of the present study was to investigate the potential associations between serum sclerostin and Dkk-1 levels and parameters of arterial stiffness in patients on maintenance hemodialysis. PATIENTS/METHODS: The study included 80 prevalent hemodialysis patients. Serum levels of sclerostin and Dkk-1 were measured by enzyme-linked immunosorbent assay (ELISA). Aortic stiffness was estimated by measurement of pulse wave velocity (PWV) and parameters of central blood pressure and wave reflections using applanation tonometry in carotid and femoral arteries (SphygmoCor@ device). Aortic stiffness indices were additionally estimated with an ambulatory device (Mobil-O-graph NG) in a subgroup of patients during 24 hours. A large set of demographic, co-morbid, laboratory and drug parameters were used in the analyses.RESULTS: Sclerostin was positively correlated with age (r=0.439, p<0.001) and BMI (r=0.270, p=0.015) and negatively with iPTH (r=-0.314, p=0.005) and Kt/V(r=-0.219, p=0.050). In contrast to sclerostin, Dkk-1 only showed a weak inverse association with age (r =-0.223, p=0.047) and no further significant correlations with any marker of vascular disease or bone metabolism was observed. The patients were dichotomized according to the median value of sclerostin (200pg/ml) and Dkk-1 (340pg/ml). Patients with high (≥200pg/ml) serum sclerostin had significantly higher PWV levels compared to patients with low serum sclerostin levels (10.63±2.71 vs 9.77±3.13, p=0.048). In contrast, PWV values were similar in patients with high and low Dkk-1 levels. In stepwise logistic regression analysis, high sclerostin levels were significantly associated with PWV values [HR: 2.778, 95% CI: 1.123-6.868, for 1 pg/ml increase], after adjustment for bone biomarkers, Dkk-1, iPTH and calcium x phosphorus product. This association lost significance only when several other parameters, which were strongly associated with arterial stiffness (age, gender, BMI, hemodialysis vintage, diabetes, hypertension and cardiovascular disease) entered the model. In contrast to the above, high Dkk-1 was not associated with high PWV levels. The comparison between the parameters of aortic stiffness, estimated with the devices Sphygmocor and Mobil-O-Graph, showed a strong association between the values of AIx@HR75 (r=0.483, p=0.023), whereas PWV was slightly underestimated with the ambulatory device. CONCLUSIONS: In hemodialysis patients sclerostin levels correlated positively with age and negatively with iPTH, whereas Dkk-1 levels were negatively associated with age. Sclerostin was significantly associated with PWV independently of classic markers of CKD-MBD. In contrast, Dkk-1 showed no association with aortic stiffness. The above findings suggest that sclerostin, but not Dkk-1 protein, plays a role in the process of media calcification and consequently in the development of arterial stiffening.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stavrinou, Eirini
  • Σταυρινού, Ειρήνη

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46819

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stavrinou, Eirini; Σταυρινού, Ειρήνη. Σκληροστίνη και πρωτεΐνη Dickkopf-1 και αρτηριακή σκληρία σε ασθενείς με χρόνια νεφρική νόσο σταδίου 5 σε χρόνια περιοδική αιμοκάθαρση. Aristotle University Of Thessaloniki (AUTH), 2019. http://hdl.handle.net/10442/hedi/46819